Explore 3 Stock Ideas & Industry Insights Download Free Report

United Health Products Inc

Company price
0.035 USD -0.01 ( 23.91%)
Last update at 2026-11-18T16:54:00Z
VOLUME
134986
Market Cap
9.72M

Momentum Score

…

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. The company was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.03
Low
0.04
High
52 Week Price Range
0.03
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on United Health Products Inc (OTCQB: UEEC) is sparse, with filings and coverage offering limited detail on its core business and revenue model. Long-term growth drivers are not well documented; prospective upside depends on improved disclosure, execution of a clarified strategy and access to capital, which investors should monitor.

Key risks include limited transparency and public disclosure, thin liquidity and volatile OTCQB trading, possible lack of audited financials or operating history, and execution and financing risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.05
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.02M
Debt / Equity
-0.45
ROE
-
Net Debt
1.96M
ROCE
62.20%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.67M -2.00M -2.62M -1.69M -30.55M
Net income -2.67M -2.00M -2.62M -1.69M -31.17M
Selling general administrative 1.99M 0.04M 0.02M 2.20M 29.56M
Selling and marketing expenses - - 1.80M - -
Gross profit - - -0.00M 0.02M 0.00M
Reconciled depreciation 0.00M 0.00M 0.00M 0.00M -
Ebit - - -2.51M -2.80M -29.80M
Ebitda - - -2.50M -1.40M -29.50M
Depreciation and amortization - - 0.00M 1.41M 0.30M
Non operating income net other - - - 1.11M -0.75M
Operating income -2.26M -2.01M -2.43M -2.80M -29.80M
Other operating expenses - - 2.43M 2.84M 29.80M
Interest expense 0.20M 0.11M 0.12M 0.08M 0.62M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.20M -0.11M -0.12M -0.08M -0.62M
Income tax expense - - 0.00M -0.00M 0.62M
Total revenue 0.00M 0.00M 0.00M 0.04M 0.00M
Total operating expenses 2.26M 0.04M 2.43M 2.82M 29.80M
Cost of revenue - - 0.00M 0.02M 0.00M
Total other income expense net -0.21M 0.12M -0.20M 1.11M -0.75M
Net income from continuing ops -2.67M -2.00M -2.82M -1.69M -30.55M
Net income applicable to common shares - - - -1.69M -30.55M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.32M 0.27M 0.28M 0.35M 0.03M
Intangible assets 0.02M 0.03M 0.03M 0.04M -
Other current assets 0.04M 0.02M 0.02M 0.02M 0.01M
Total liab 4.19M 2.71M 2.00M 2.42M 1.17M
Total stockholder equity -3.88M -2.44M -1.71M -2.06M -1.14M
Deferred long term liab - - - 0.24M -
Other current liab 0.14M 0.78M 0.23M 0.47M 0.12M
Common stock - 0.25M 0.24M 0.23M 0.23M
Capital stock 0.26M 0.25M 0.24M 0.23M 0.23M
Retained earnings -81.37M -78.70M -76.70M -74.08M -72.39M
Other assets - - 0.00M 0.24M -
Cash 0.07M 0.17M 0.10M 0.01M 0.02M
Total current liabilities 3.94M 1.64M 1.95M 2.42M 1.17M
Current deferred revenue - - -0.03M - -
Net debt 1.96M 0.94M 0.66M 0.67M 0.20M
Short term debt - 0.03M 0.74M 0.69M 0.22M
Short long term debt 1.78M - 0.71M 0.69M 0.22M
Short long term debt total - 1.11M 0.76M 0.69M 0.22M
Other stockholder equity - 76.00M 74.74M 71.78M 71.02M
Total current assets 0.11M 0.19M 0.15M 0.07M 0.03M
Net tangible assets - - - -2.10M -1.14M
Long term debt 0.25M 1.06M - - -
Inventory 0.00M 0.00M 0.03M 0.03M 0.00M
Accounts payable 1.05M 0.83M 0.99M 1.26M 0.83M
Common stock total equity - - - 0.23M 0.23M
Retained earnings total equity - - - -74.08M -72.39M
Non currrent assets other - 0.00M 0.02M 0.24M -
Non current assets total 0.21M 0.08M 0.13M 0.28M 0.00M
Capital lease obligations 0.02M 0.05M 0.08M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M -0.00M -0.04M 0.00M
Change to liabilities - - - 0.94M 1.22M
Total cashflows from investing activities - - - -0.04M -0.04M
Net borrowings 1.02M 0.35M -0.02M 0.52M 0.32M
Total cash from financing activities 1.08M 1.27M 2.29M 0.65M 0.80M
Change to operating activities - - - 0.56M 0.64M
Net income -2.67M -2.00M -2.62M -1.69M -30.55M
Change in cash -0.10M 0.07M 0.08M -0.01M -0.02M
Begin period cash flow 0.17M 0.10M 0.01M 0.02M 0.05M
End period cash flow 0.07M 0.17M 0.10M 0.01M 0.02M
Total cash from operating activities -1.19M -1.19M -2.20M -0.62M -0.83M
Issuance of capital stock 0.07M 0.93M 1.81M 0.18M 0.48M
Depreciation 0.00M 0.00M 0.00M 0.00M 0.61M
Other cashflows from investing activities - - -0.00M - -
Change to inventory 0.00M 0.03M 0.00M -0.03M 0.00M
Sale purchase of stock - - 0.00M -0.05M 0.48M
Other cashflows from financing activities - -0.01M 2.30M 0.84M 0.32M
Change to netincome - - - 0.48M 27.68M
Capital expenditures 0.00M 0.00M 0.00M 0.04M 0.00M
Cash flows other operating - - - -0.33M -0.01M
Cash and cash equivalents changes - - - -0.01M -0.02M
Change in working capital 0.39M 0.51M -0.03M 1.16M 1.33M
Stock based compensation 1.12M 0.38M 0.46M 0.48M -
Other non cash items 0.00M -0.08M -0.04M -0.58M 28.39M
Free cash flow -1.19M -1.19M -2.20M -0.66M -0.83M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
UEEC
United Health Products Inc
-0.01
23.91%
0.04 - - 1445.03 5427.57 1726.93 -10.10
ISRG
Intuitive Surgical Inc
-3.79
0.88%
426.74 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
2.30
1.17%
199.30 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
1.21
1.23%
99.42 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
0.74
0.34%
216.16 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

United Health Products Inc

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. The company was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

520 Fellowship Road, Mount Laurel, NJ, United States, 08054

475 755 1005

Name Title Year Born
Mr. Brian D. Thom CEO & Chairman Pro Tempore NA
Mr. Kristofer Heaton VP of Fin. & Principal Financial Officer 1979
Mr. John Phillips VP of Marketing & Commercial Strategy NA
Dr. Gerard Abate M.D. Chief Medical Director & Member of Medical Advisory Board NA
Mr. Brian D. Thom CEO, Interim Principal Financial Officer & Chairman NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…